{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:20:00Z","timestamp":1780626000550,"version":"3.54.1"},"reference-count":33,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007729","name":"Ministerie van Buitenlandse Zaken","doi-asserted-by":"publisher","award":["Activity # 4000000282"],"award-info":[{"award-number":["Activity # 4000000282"]}],"id":[{"id":"10.13039\/501100007729","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anonymous Foundation"},{"DOI":"10.13039\/100013986","name":"Government of the United Kingdom","doi-asserted-by":"publisher","award":["Project # 203177 -101"],"award-info":[{"award-number":["Project # 203177 -101"]}],"id":[{"id":"10.13039\/100013986","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,3,12]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to assess the safety and effectiveness of self-managed misoprostol abortions obtained outside of the formal health system in Lagos State, Nigeria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This was a prospective cohort study among women using misoprostol-containing medications purchased from drug sellers. Three telephone-administered surveys were conducted over 1\u2009month.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Data were collected in 2018 in six local government areas in Lagos State.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Drug sellers attempted to recruit all women who purchased misoprostol-containing medication. To remain in the study, participants had to be female and aged 18\u201349, and had to have purchased the medication for the purpose of abortion. Of 501 women initially recruited, 446 were eligible for the full study, and 394 completed all three surveys.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Using self-reported measures, we assessed the quality of information provided by drug sellers; the prevalence of potential complications; and the proportion with completed abortions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Although drug sellers provided inadequate information about the pills, 94% of the sample reported a complete abortion without surgical intervention about 1\u2009month after taking the medication. Assuming a conservative scenario where all individuals lost to follow-up had failed terminations, the completion rate dropped to 87%. While 86 women reported physical symptoms suggestive of complications, only six of them reported wanting or needing health facility care and four subsequently obtained care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Drug sellers are an important source of medical abortion in this setting. Despite the limitations of self-report, many women appear to have effectively self-administered misoprostol. Additional research is needed to expand the evidence on the safety and effectiveness of self-use of misoprostol for abortion in restrictive settings, and to inform approaches that support the health and well-being of people who use this method of abortion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-034670","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T06:35:44Z","timestamp":1588746944000},"page":"e034670","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":55,"title":["Women\u2019s self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1318-2419","authenticated-orcid":false,"given":"Melissa","family":"Stillman","sequence":"first","affiliation":[{"name":"Department of Research, Guttmacher Institute, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4150-9976","authenticated-orcid":false,"given":"Onikepe","family":"Owolabi","sequence":"additional","affiliation":[{"name":"Department of Research, Guttmacher Institute, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3893-8024","authenticated-orcid":false,"given":"Adesegun O","family":"Fatusi","sequence":"additional","affiliation":[{"name":"Department of Research, Guttmacher Institute, New York, New York, USA"},{"name":"Academy for Health Development (AHEAD), Ile-Ife, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8652-9359","authenticated-orcid":false,"given":"Akanni I","family":"Akinyemi","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, Massachusetts, United States"},{"name":"Department of Demography and Social Statistics, Obafemi Awolowo University, Ile-Ife, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9084-7771","authenticated-orcid":false,"given":"Amanda L","family":"Berry","sequence":"additional","affiliation":[{"name":"Department of Research, Guttmacher Institute, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6576-398X","authenticated-orcid":false,"given":"Temitope P","family":"Erinfolami","sequence":"additional","affiliation":[{"name":"Department of Demography and Social Statistics, Obafemi Awolowo University, Ile-Ife, Nigeria"},{"name":"Centre for Research, Evaluation, Resources and Development (CRERD), Ile-Ife, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8394-133X","authenticated-orcid":false,"given":"Olalekan S","family":"Olagunju","sequence":"additional","affiliation":[{"name":"Department of Demography and Social Statistics, Obafemi Awolowo University, Ile-Ife, Nigeria"},{"name":"Centre for Research, Evaluation, Resources and Development (CRERD), Ile-Ife, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5494-0415","authenticated-orcid":false,"given":"Heini","family":"V\u00e4is\u00e4nen","sequence":"additional","affiliation":[{"name":"Department of Social Statistics and Demography, University of Southampton, Southampton, Hampshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3220-9477","authenticated-orcid":false,"given":"Akinrinola","family":"Bankole","sequence":"additional","affiliation":[{"name":"Department of Research, Guttmacher Institute, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"2025121601230063000_10.5.e034670.1","doi-asserted-by":"crossref","unstructured":"Singh S , Remez L , Sedgh G . Abortion worldwide 2017: uneven progress and unequal access. Guttmacher Institute, 2018.","DOI":"10.1363\/2018.29199"},{"key":"2025121601230063000_10.5.e034670.2","unstructured":"World Health Organization . Medical management of abortion. Geneva: World Health Organization, 2018."},{"key":"2025121601230063000_10.5.e034670.3","unstructured":"World Health Organization . Health worker roles in providing safe abortion care and post-abortion contraception. Geneva, Switzerland: World Health Organization, 2015."},{"key":"2025121601230063000_10.5.e034670.4","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division . World population prospects 2019. United Nations, 2019. https:\/\/population.un.org\/wpp"},{"key":"2025121601230063000_10.5.e034670.5","unstructured":"Center for Reproductive Rights . The World\u2019s Abortion Laws Map. no date. Available: https:\/\/reproductiverights.org\/worldabortionlaws"},{"key":"2025121601230063000_10.5.e034670.6","unstructured":"Bell S , Omoluabi E , Shankar M , et al . Abortion incidence and safety in Nigeria: findings from a population-based survey. Austin, Texas, 2019. Available: http:\/\/paa2019.populationassociation.org\/uploads\/190710 [Accessed 14 Aug 2019]."},{"key":"2025121601230063000_10.5.e034670.7","doi-asserted-by":"crossref","unstructured":"Akiode A , Fetters T , Okoh M , et al . The availability of misoprostol in pharmacies and patent medicine stores in two Nigerian cities. Ebonyi Med J 2010.","DOI":"10.4314\/ebomed.v9i2.71688"},{"key":"2025121601230063000_10.5.e034670.8","doi-asserted-by":"publisher","DOI":"10.1783\/147118906778586660"},{"key":"2025121601230063000_10.5.e034670.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209415","article-title":"Trends in misoprostol use and abortion complications: a cross-sectional study from nine referral hospitals in Nigeria","volume":"13","author":"Bello","year":"2018","journal-title":"PLoS One"},{"key":"2025121601230063000_10.5.e034670.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117165"},{"key":"2025121601230063000_10.5.e034670.11","doi-asserted-by":"publisher","DOI":"10.1057\/jphp.2012.11"},{"key":"2025121601230063000_10.5.e034670.12","doi-asserted-by":"publisher","DOI":"10.1111\/sifp.12049"},{"key":"2025121601230063000_10.5.e034670.13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijgo.2015.07.008","article-title":"Client-pharmacy worker interactions regarding medical abortion in Zambia in 2009 and 2011","volume":"132","author":"Hendrickson","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"2025121601230063000_10.5.e034670.14","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2013-100821"},{"key":"2025121601230063000_10.5.e034670.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-017-1394-5","article-title":"Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study","volume":"17","author":"Reiss","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025121601230063000_10.5.e034670.16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.contraception.2017.11.006","article-title":"Provision of menstrual regulation with medication among pharmacies in three municipal districts of Bangladesh: a situation analysis","volume":"97","author":"Huda","year":"2018","journal-title":"Contraception"},{"key":"2025121601230063000_10.5.e034670.17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.contraception.2017.08.002","article-title":"Feasibility of assessing the safety and effectiveness of menstrual regulation medications purchased from pharmacies in Bangladesh: a prospective cohort study","volume":"97","author":"Footman","year":"2018","journal-title":"Contraception"},{"key":"2025121601230063000_10.5.e034670.18","first-page":"S172","article-title":"Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy","volume":"99 Suppl 2","author":"Fa\u00fandes","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"2025121601230063000_10.5.e034670.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60914-3"},{"key":"2025121601230063000_10.5.e034670.20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijgo.2012.03.039","article-title":"Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam","volume":"118","author":"Blum","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"2025121601230063000_10.5.e034670.21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/AOG.0000000000003017","article-title":"Efficacy of misoprostol alone for first-trimester medical abortion: a systematic review","volume":"133","author":"Raymond","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2025121601230063000_10.5.e034670.22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rhm.2015.06.004","article-title":"Safe abortion information hotlines: an effective strategy for increasing women's access to safe abortions in Latin America","volume":"23","author":"Drovetta","year":"2015","journal-title":"Reprod Health Matters"},{"key":"2025121601230063000_10.5.e034670.23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0968-8080(14)43786-8","article-title":"Women\u2019s experiences with the use of medical abortion in a legally restricted context: the case of Argentina","volume":"22","author":"Ramos","year":"2014","journal-title":"Reprod Health Matters"},{"key":"2025121601230063000_10.5.e034670.24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.contraception.2017.09.008","article-title":"Experience of clandestine use of medical abortion among university students in Chile: a qualitative study","volume":"97","author":"Palma Manr\u00edquez","year":"2018","journal-title":"Contraception"},{"key":"2025121601230063000_10.5.e034670.25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.contraception.2017.12.005","article-title":"Complications with use of misoprostol for abortion in Madagascar: between ease of access and lack of information","volume":"97","author":"Pourette","year":"2018","journal-title":"Contraception"},{"key":"2025121601230063000_10.5.e034670.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2014.05.026","article-title":"Pharmacy recruitment of misoprostol users in Mexico: a feasibility study","volume":"90","author":"Brahmi","year":"2014","journal-title":"Contraception"},{"key":"2025121601230063000_10.5.e034670.27","unstructured":"PMA . PMA2020. 2018. Abortion Survey Results: Nigeria, 2020. https:\/\/www.pma2020.org\/sites\/default\/files\/AbortionModule_Brief_111518.pdf"},{"key":"2025121601230063000_10.5.e034670.28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ijgo.12181","article-title":"Figo's updated recommendations for misoprostol used alone in gynecology and obstetrics","volume":"138","author":"Morris","year":"2017","journal-title":"Int J Gynecol Obstet"},{"key":"2025121601230063000_10.5.e034670.29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.contraception.2017.06.006","article-title":"Community-Based distribution of misoprostol for early abortion: evaluation of a program along the Thailand-Burma border","volume":"96","author":"Foster","year":"2017","journal-title":"Contraception"},{"key":"2025121601230063000_10.5.e034670.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2018-200102"},{"key":"2025121601230063000_10.5.e034670.31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0968-8080(08)31371-8","article-title":"Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management","volume":"16","author":"Gemzell-Danielsson","year":"2008","journal-title":"Reprod Health Matters"},{"key":"2025121601230063000_10.5.e034670.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2006.09.009"},{"key":"2025121601230063000_10.5.e034670.33","article-title":"Follow-Up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses","author":"Schmidt-Hansen","year":"2019","journal-title":"Am J Obstet Gynecol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-034670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:23:13Z","timestamp":1765876993000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-034670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,5]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/bmjopen-2019-034670"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-034670","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}